Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	939.84	1,061	1,079	957.7	847.39	745.38
Revenue Growth (YoY)	-10.64%	-1.63%	12.63%	13.02%	13.69%	-23.78%
Cost of Revenue	704.62	790.64	797.99	680.07	583.79	465.23
Gross Profit	235.23	270.45	280.67	277.63	263.6	280.15
Selling, General & Admin	196.84	189.5	203.59	205.03	196.16	245.51
Research & Development	17.59	17.59	18.84	-	-	-
Other Operating Expenses	-26.55	-30	-20.88	-22.35	-17.42	-45.76
Operating Expenses	188.08	177.29	201.99	197.29	192.36	214.28
Operating Income	47.15	93.16	78.68	80.34	71.24	65.87
Interest Expense	-12.05	-13.28	-11.52	-12.29	-11.78	-15.16
Interest & Investment Income	10.54	8.36	11.52	1.75	2.8	17.17
Earnings From Equity Investments	18.25	19.1	8.6	7.64	8.99	12.4
Currency Exchange Gain (Loss)	-11.14	-10.19	-4.97	-5.81	-3.09	-5.01
Other Non Operating Income (Expenses)	-2.91	-2.91	-	-	-	-0.37
EBT Excluding Unusual Items	49.83	94.23	82.31	71.63	68.16	74.91
Gain (Loss) on Sale of Investments	1.63	-4.25	12.94	2.89	0.47	-3.36
Asset Writedown	2.09	5.16	-1.36	-7.3	0.8	-1.6
Other Unusual Items	0.37	0.37	-	0.36	-	0.95
Pretax Income	53.93	95.52	93.89	67.58	69.43	70.89
Income Tax Expense	13.65	21.05	32.29	24.04	18.22	20
Earnings From Continuing Operations	40.28	74.47	61.59	43.54	51.21	50.89
Minority Interest in Earnings	-34.85	-32.91	-23.5	-20.8	-20.89	-39.17
Net Income	5.43	41.56	38.1	22.74	30.32	11.72
Net Income to Common	5.43	41.56	38.1	22.74	30.32	11.72
Net Income Growth	-82.53%	9.09%	67.52%	-24.99%	158.78%	-73.02%
Shares Outstanding (Basic)	568	576	592	607	607	614
Shares Outstanding (Diluted)	568	576	592	607	607	614
Shares Change (YoY)	-3.99%	-2.66%	-2.49%	0.04%	-1.29%	-1.00%
EPS (Basic)	0.01	0.07	0.06	0.04	0.05	0.02
EPS (Diluted)	0.01	0.07	0.06	0.04	0.05	0.02
EPS Growth	-81.81%	12.06%	71.79%	-25.02%	162.17%	-72.75%
Free Cash Flow	-	94.73	-63.25	93.04	22.88	113.66
Free Cash Flow Per Share	-	0.16	-0.11	0.15	0.04	0.18
Dividend Per Share	-	0.030	0.031	0.022	0.019	0.005
Dividend Growth	-	-2.91%	40.74%	11.79%	254.55%	-73.68%
Gross Margin	25.03%	25.49%	26.02%	28.99%	31.11%	37.59%
Operating Margin	5.02%	8.78%	7.29%	8.39%	8.41%	8.84%
Profit Margin	0.58%	3.92%	3.53%	2.38%	3.58%	1.57%
Free Cash Flow Margin	-	8.93%	-5.86%	9.71%	2.70%	15.25%
EBITDA	58.55	104.64	88.52	107.39	96.46	90.2
EBITDA Margin	6.23%	9.86%	8.21%	11.21%	11.38%	12.10%
D&A For EBITDA	11.4	11.49	9.84	27.05	25.22	24.32
EBIT	47.15	93.16	78.68	80.34	71.24	65.87
EBIT Margin	5.02%	8.78%	7.29%	8.39%	8.41%	8.84%
Effective Tax Rate	25.30%	22.04%	34.39%	35.57%	26.25%	28.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.